<?xml version="1.0" encoding="UTF-8"?>
<ref id="B4-viruses-12-00504">
 <label>4.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Noshi</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Kitano</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Taniguchi</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Yamamoto</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Omoto</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Baba</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Hashimoto</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Ishida</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Kushima</surname>
    <given-names>Y.</given-names>
   </name>
   <name>
    <surname>Hattori</surname>
    <given-names>K.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunit</article-title>
  <source>Antivir. Res.</source>
  <year>2018</year>
  <volume>160</volume>
  <fpage>109</fpage>
  <lpage>117</lpage>
  <pub-id pub-id-type="doi">10.1016/j.antiviral.2018.10.008</pub-id>
  <pub-id pub-id-type="pmid">30316915</pub-id>
 </element-citation>
</ref>
